Tag: CYP3A4 inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CYP3A4 inhibitors

Paxlovid EUA revised, emergency use still authorized in pediatric patients

Added to Collection on: 2024-01-29 18:53:14

Tags for this article:

COVID-19 drug development
CYP3A4 inhibitors
Nirmatrelvir/ritonavir
Ritonavir
Nirmatrelvir
Pfizer
Emergency use authorization
3C-like protease
Treatment and management of COVID-19

Click the tags to see associated articles and topics

View Article Details
Paxlovid EUA Revision Narrows Emergency Use to Pediatric Patients - Drug Topics

Added to Collection on: 2024-01-29 23:14:26

Tags for this article:

COVID-19 drug development
CYP3A4 inhibitors
Nirmatrelvir/ritonavir
Ritonavir
Nirmatrelvir
Pfizer
Emergency use authorization
3C-like protease
Treatment and management of COVID-19

Click the tags to see associated articles and topics

View Article Details
Lupin Secures U S FDA Approval For Generic Dronedarone Tablets - BW Healthcare

Added to Collection on: 2024-02-01 13:22:26

Tags for this article:

CYP3A4 inhibitors
Antiarrhythmic agents
CYP2D6 inhibitors
Dronedarone
Sulfonamides
Sanofi
Atrial fibrillation
Sanofi-Aventis U.S. LLC

Click the tags to see associated articles and topics

View Article Details
Study finds link between high niacin levels and heart disease - USTimesPost

Added to Collection on: 2024-02-19 16:37:29

Tags for this article:

B vitamins
CYP2D6 inhibitors
CYP3A4 inhibitors
GABAA receptor positive allosteric modulators
Cardiology
Niacin
Vitamin B3
Cardiovascular disease
Low-density lipoprotein
Lipid-lowering agent
Cholesterol
Atherosclerosis
Stanley Hazen

Click the tags to see associated articles and topics

View Article Details
UPDATE 2-FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound

Added to Collection on: 2024-03-06 17:53:29

Tags for this article:

CYP3A4 inhibitors
COVID-19 drug development
COVID-19 vaccination in the United States
Nirmatrelvir/ritonavir
Pfizer
Food and Drug Administration
Antiviral drug
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
COVID-19 Treatments Locator Tool: Request to Health Care Providers | HHS/ASPR

Added to Collection on: 2024-03-11 23:32:49

Tags for this article:

COVID-19 drug development
CYP3A4 inhibitors
Treatment and management of COVID-19
Nirmatrelvir/ritonavir
COVID-19 pandemic
Remdesivir
Ritonavir

Click the tags to see associated articles and topics

View Article Details
New drug candidate designed at the atomic level could help halt emerging SARS-CoV-2 variants

Added to Collection on: 2024-03-14 19:49:56

Tags for this article:

CYP3A4 inhibitors
COVID-19 drug development
Amides
Ureas
Cyclopropanes
Ritonavir
Protease inhibitor
Nirmatrelvir/ritonavir
Nirmatrelvir
SARS-CoV-2
Boceprevir
COVID-19 pandemic
Michael Lin

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details
The Rise and Fall of Paxlovid - HIV and ID Observations

Added to Collection on: 2024-04-09 13:52:16

Tags for this article:

CYP3A4 inhibitors
COVID-19 drug development
Nirmatrelvir/ritonavir
Ritonavir
Nirmatrelvir

Click the tags to see associated articles and topics

View Article Details
Pfizer Lied to Us Again - Brownstone Institute

Added to Collection on: 2024-04-17 20:03:52

Tags for this article:

COVID-19 drug development
CYP3A4 inhibitors
COVID-19 vaccination in the United States
Nirmatrelvir/ritonavir
Virus research
Treatment and management of COVID-19
Pfizer
Ritonavir
COVID-19 pandemic
COVID-19 vaccine
Nirmatrelvir
Operation Warp Speed
Anthony Fauci

Click the tags to see associated articles and topics

View Article Details